Skip to Content
Merck
  • Spatial proteomics defines the content of trafficking vesicles captured by golgin tethers.

Spatial proteomics defines the content of trafficking vesicles captured by golgin tethers.

Nature communications (2020-11-27)
John J H Shin, Oliver M Crook, Alicia C Borgeaud, Jérôme Cattin-Ortolá, Sew Y Peak-Chew, Lisa M Breckels, Alison K Gillingham, Jessica Chadwick, Kathryn S Lilley, Sean Munro
ABSTRACT

Intracellular traffic between compartments of the secretory and endocytic pathways is mediated by vesicle-based carriers. The proteomes of carriers destined for many organelles are ill-defined because the vesicular intermediates are transient, low-abundance and difficult to purify. Here, we combine vesicle relocalisation with organelle proteomics and Bayesian analysis to define the content of different endosome-derived vesicles destined for the trans-Golgi network (TGN). The golgin coiled-coil proteins golgin-97 and GCC88, shown previously to capture endosome-derived vesicles at the TGN, were individually relocalised to mitochondria and the content of the subsequently re-routed vesicles was determined by organelle proteomics. Our findings reveal 45 integral and 51 peripheral membrane proteins re-routed by golgin-97, evidence for a distinct class of vesicles shared by golgin-97 and GCC88, and various cargoes specific to individual golgins. These results illustrate a general strategy for analysing intracellular sub-proteomes by combining acute cellular re-wiring with high-resolution spatial proteomics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human GCC1
Millipore
Benzonase® Nuclease, ≥250 units/μL, ≥90% (SDS-PAGE), recombinant, expressed in E. coli, buffered aqueous glycerol solution
Sigma-Aldrich
Iodoacetamide, ≥99% (NMR), crystalline